{"DataElement":{"publicId":"6776853","version":"1","preferredName":"International Prognostic Index Risk Assessment Score","preferredDefinition":"Numerical representation for the assessment of predicted risk of disease recurrence and survival following therapy for non-Hodgkin lymphoma patients.","longName":"IPI_RISK_SCR","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6776845","version":"1","preferredName":"International Prognostic Index Risk Assessment","preferredDefinition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))_The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._The final result of a determination of the value, significance, or extent of.","longName":"6776842v1.0:6776843v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6776842","version":"1","preferredName":"International Prognostic Index","preferredDefinition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))","longName":"C20118","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Prognostic Index","conceptCode":"C20118","definition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFCF464-6516-4C11-E053-F662850AFFDE","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6776843","version":"1","preferredName":"Risk Assessment","preferredDefinition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:The final result of a determination of the value, significance, or extent of.","longName":"C17102:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFCF464-6527-4C11-E053-F662850AFFDE","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFCF464-6538-4C11-E053-F662850AFFDE","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"COOPERM","dateModified":"2019-06-11","changeDescription":"Created for NCI-INC0386214-CDE Import - IPI Score request by Pam. 6.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6776847","version":"1","preferredName":"IPI Risk Score","preferredDefinition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))_The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"IPI_RISK_SCR","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"4-5","valueDescription":"High risk","ValueMeaning":{"publicId":"6776848","version":"1","preferredName":"High risk","longName":"6776848","preferredDefinition":"A score of 4 or 5 on the International Prognostic Index indicating that an individual has a high risk of progression of non-Hodgkin lymphoma and a 5 year survival of 32%.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IPI Score 4-5","conceptCode":"C161650","definition":"A score of 4 or 5 on the International Prognostic Index indicating that an individual has a high risk of progression of non-Hodgkin lymphoma and a 5 year survival of 32%.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD0559-9684-5A43-E053-F662850A5713","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"SOKKERL","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AFD0559-969C-5A43-E053-F662850A5713","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","deletedIndicator":"No"},{"value":"3","valueDescription":"High-intermediate Risk","ValueMeaning":{"publicId":"6776849","version":"1","preferredName":"High-intermediate Risk","longName":"6776849","preferredDefinition":"A score of 3 on the International Prognostic Index indicating that an individual has a high-intermediate risk of progression of non-Hodgkin lymphoma and a 5 year survival of 46%.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IPI Score 3","conceptCode":"C161648","definition":"A score of 3 on the International Prognostic Index indicating that an individual has a high-intermediate risk of progression of non-Hodgkin lymphoma and a 5 year survival of 46%.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD0559-96A7-5A43-E053-F662850A5713","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"SOKKERL","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AFD0559-96C0-5A43-E053-F662850A5713","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","deletedIndicator":"No"},{"value":"2","valueDescription":"Low-intermediate Risk","ValueMeaning":{"publicId":"6776850","version":"1","preferredName":"Low-intermediate Risk","longName":"6776850","preferredDefinition":"A score of 2 on the International Prognostic Index indicating that an individual has a low-intermediate risk of progression of non-Hodgkin lymphoma and a 5 year survival of 69%.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IPI Score 2","conceptCode":"C161647","definition":"A score of 2 on the International Prognostic Index indicating that an individual has a low-intermediate risk of progression of non-Hodgkin lymphoma and a 5 year survival of 69%.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD0559-96CA-5A43-E053-F662850A5713","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"SOKKERL","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AFD0559-96E3-5A43-E053-F662850A5713","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","deletedIndicator":"No"},{"value":"0-1","valueDescription":"Low Risk","ValueMeaning":{"publicId":"6776851","version":"1","preferredName":"Low Risk","longName":"6776851","preferredDefinition":"A score of 0 or 1 on the International Prognostic Index indicating that an individual has a low risk of progression of non-Hodgkin lymphoma and a 5 year survival of 73%.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IPI Score 0-1","conceptCode":"C161646","definition":"A score of 0 or 1 on the International Prognostic Index indicating that an individual has a low risk of progression of non-Hodgkin lymphoma and a 5 year survival of 73%.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD0559-96ED-5A43-E053-F662850A5713","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"SOKKERL","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AFD0559-9705-5A43-E053-F662850A5713","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6776846","version":"1","preferredName":"International Prognostic Index Risk Score","preferredDefinition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org)):The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C20118:C17102:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Prognostic Index","conceptCode":"C20118","definition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD0559-965F-5A43-E053-F662850A5713","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD0559-9670-5A43-E053-F662850A5713","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"COOPERM","dateModified":"2019-06-11","changeDescription":"Created for NCI-INC0386214-CDE Import - IPI Score by Pam. 6.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"International Prognostic Inde","type":"Preferred Question Text","description":"International Prognostic Index (IPI) score","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD0EE0-F127-6247-E053-F662850A7A6B","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"COOPERM","dateModified":"2019-06-11","changeDescription":"Created for NCI-INC0386214-CDE Import - IPI Score request by Pam. 6.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}